Global Next Generation Sequencing (NGS) Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Next Generation Sequencing (NGS) Revenue
• 1.4 Market by Type
  • 1.4.1 Global Next Generation Sequencing (NGS) Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Consumables
  • 1.4.3 Platforms
  • 1.4.4 Services
• 1.5 Market by Application
  • 1.5.1 Global Next Generation Sequencing (NGS) Market Share by Application: 2020 VS 2026
  • 1.5.2 Academic & Government Research Institutes
  • 1.5.3 Pharmaceutical Companies
  • 1.5.4 Biotechnology Companies
  • 1.5.5 Hospitals & Clinics
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Next Generation Sequencing (NGS) Market Perspective (2015-2026)
• 2.2 Global Next Generation Sequencing (NGS) Growth Trends by Regions
  • 2.2.1 Next Generation Sequencing (NGS) Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Next Generation Sequencing (NGS) Historic Market Share by Regions (2015-2020)
  • 2.2.3 Next Generation Sequencing (NGS) Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Next Generation Sequencing (NGS) Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Next Generation Sequencing (NGS) Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Next Generation Sequencing (NGS) Players by Market Size
  • 3.1.1 Global Top Next Generation Sequencing (NGS) Players by Revenue (2015-2020)
  • 3.1.2 Global Next Generation Sequencing (NGS) Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Next Generation Sequencing (NGS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Next Generation Sequencing (NGS) Market Concentration Ratio
  • 3.2.1 Global Next Generation Sequencing (NGS) Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Next Generation Sequencing (NGS) Revenue in 2019
• 3.3 Next Generation Sequencing (NGS) Key Players Head office and Area Served
• 3.4 Key Players Next Generation Sequencing (NGS) Product Solution and Service
• 3.5 Date of Enter into Next Generation Sequencing (NGS) Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Next Generation Sequencing (NGS) Historic Market Size by Type (2015-2020)
• 4.2 Global Next Generation Sequencing (NGS) Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Next Generation Sequencing (NGS) Market Size by Application (2015-2020)
• 5.2 Global Next Generation Sequencing (NGS) Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Next Generation Sequencing (NGS) Market Size (2015-2020)
• 6.2 Next Generation Sequencing (NGS) Key Players in North America (2019-2020)
• 6.3 North America Next Generation Sequencing (NGS) Market Size by Type (2015-2020)
• 6.4 North America Next Generation Sequencing (NGS) Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Next Generation Sequencing (NGS) Market Size (2015-2020)
• 7.2 Next Generation Sequencing (NGS) Key Players in Europe (2019-2020)
• 7.3 Europe Next Generation Sequencing (NGS) Market Size by Type (2015-2020)
• 7.4 Europe Next Generation Sequencing (NGS) Market Size by Application (2015-2020)

8 China

• 8.1 China Next Generation Sequencing (NGS) Market Size (2015-2020)
• 8.2 Next Generation Sequencing (NGS) Key Players in China (2019-2020)
• 8.3 China Next Generation Sequencing (NGS) Market Size by Type (2015-2020)
• 8.4 China Next Generation Sequencing (NGS) Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Next Generation Sequencing (NGS) Market Size (2015-2020)
• 9.2 Next Generation Sequencing (NGS) Key Players in Japan (2019-2020)
• 9.3 Japan Next Generation Sequencing (NGS) Market Size by Type (2015-2020)
• 9.4 Japan Next Generation Sequencing (NGS) Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Next Generation Sequencing (NGS) Market Size (2015-2020)
• 10.2 Next Generation Sequencing (NGS) Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Next Generation Sequencing (NGS) Market Size by Type (2015-2020)
• 10.4 Southeast Asia Next Generation Sequencing (NGS) Market Size by Application (2015-2020)

11 India

• 11.1 India Next Generation Sequencing (NGS) Market Size (2015-2020)
• 11.2 Next Generation Sequencing (NGS) Key Players in India (2019-2020)
• 11.3 India Next Generation Sequencing (NGS) Market Size by Type (2015-2020)
• 11.4 India Next Generation Sequencing (NGS) Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Next Generation Sequencing (NGS) Market Size (2015-2020)
• 12.2 Next Generation Sequencing (NGS) Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Next Generation Sequencing (NGS) Market Size by Type (2015-2020)
• 12.4 Central & South America Next Generation Sequencing (NGS) Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Illumina
  • 13.1.1 Illumina Company Details
  • 13.1.2 Illumina Business Overview
  • 13.1.3 Illumina Next Generation Sequencing (NGS) Introduction
  • 13.1.4 Illumina Revenue in Next Generation Sequencing (NGS) Business (2015-2020))
  • 13.1.5 Illumina Recent Development
• 13.2 Thermo Fisher Scientific
  • 13.2.1 Thermo Fisher Scientific Company Details
  • 13.2.2 Thermo Fisher Scientific Business Overview
  • 13.2.3 Thermo Fisher Scientific Next Generation Sequencing (NGS) Introduction
  • 13.2.4 Thermo Fisher Scientific Revenue in Next Generation Sequencing (NGS) Business (2015-2020)
  • 13.2.5 Thermo Fisher Scientific Recent Development
• 13.3 Pacific Biosciences of California
  • 13.3.1 Pacific Biosciences of California Company Details
  • 13.3.2 Pacific Biosciences of California Business Overview
  • 13.3.3 Pacific Biosciences of California Next Generation Sequencing (NGS) Introduction
  • 13.3.4 Pacific Biosciences of California Revenue in Next Generation Sequencing (NGS) Business (2015-2020)
  • 13.3.5 Pacific Biosciences of California Recent Development
• 13.4 Beijing Genomics Institute
  • 13.4.1 Beijing Genomics Institute Company Details
  • 13.4.2 Beijing Genomics Institute Business Overview
  • 13.4.3 Beijing Genomics Institute Next Generation Sequencing (NGS) Introduction
  • 13.4.4 Beijing Genomics Institute Revenue in Next Generation Sequencing (NGS) Business (2015-2020)
  • 13.4.5 Beijing Genomics Institute Recent Development
• 13.5 Qiagen
  • 13.5.1 Qiagen Company Details
  • 13.5.2 Qiagen Business Overview
  • 13.5.3 Qiagen Next Generation Sequencing (NGS) Introduction
  • 13.5.4 Qiagen Revenue in Next Generation Sequencing (NGS) Business (2015-2020)
  • 13.5.5 Qiagen Recent Development
• 13.6 Roche
  • 13.6.1 Roche Company Details
  • 13.6.2 Roche Business Overview
  • 13.6.3 Roche Next Generation Sequencing (NGS) Introduction
  • 13.6.4 Roche Revenue in Next Generation Sequencing (NGS) Business (2015-2020)
  • 13.6.5 Roche Recent Development
• 13.7 Agilent Technologies
  • 13.7.1 Agilent Technologies Company Details
  • 13.7.2 Agilent Technologies Business Overview
  • 13.7.3 Agilent Technologies Next Generation Sequencing (NGS) Introduction
  • 13.7.4 Agilent Technologies Revenue in Next Generation Sequencing (NGS) Business (2015-2020)
  • 13.7.5 Agilent Technologies Recent Development
• 13.8 Perkinelmer
  • 13.8.1 Perkinelmer Company Details
  • 13.8.2 Perkinelmer Business Overview
  • 13.8.3 Perkinelmer Next Generation Sequencing (NGS) Introduction
  • 13.8.4 Perkinelmer Revenue in Next Generation Sequencing (NGS) Business (2015-2020)
  • 13.8.5 Perkinelmer Recent Development
• 13.9 Genomatix
  • 13.9.1 Genomatix Company Details
  • 13.9.2 Genomatix Business Overview
  • 13.9.3 Genomatix Next Generation Sequencing (NGS) Introduction
  • 13.9.4 Genomatix Revenue in Next Generation Sequencing (NGS) Business (2015-2020)
  • 13.9.5 Genomatix Recent Development
• 13.10 PierianDx
  • 13.10.1 PierianDx Company Details
  • 13.10.2 PierianDx Business Overview
  • 13.10.3 PierianDx Next Generation Sequencing (NGS) Introduction
  • 13.10.4 PierianDx Revenue in Next Generation Sequencing (NGS) Business (2015-2020)
  • 13.10.5 PierianDx Recent Development
• 13.11 Eurofins Scientific
  • 10.11.1 Eurofins Scientific Company Details
  • 10.11.2 Eurofins Scientific Business Overview
  • 10.11.3 Eurofins Scientific Next Generation Sequencing (NGS) Introduction
  • 10.11.4 Eurofins Scientific Revenue in Next Generation Sequencing (NGS) Business (2015-2020)
  • 10.11.5 Eurofins Scientific Recent Development
• 13.12 Gatc Biotech
  • 10.12.1 Gatc Biotech Company Details
  • 10.12.2 Gatc Biotech Business Overview
  • 10.12.3 Gatc Biotech Next Generation Sequencing (NGS) Introduction
  • 10.12.4 Gatc Biotech Revenue in Next Generation Sequencing (NGS) Business (2015-2020)
  • 10.12.5 Gatc Biotech Recent Development
• 13.13 Oxford Nanopore Technologies
  • 10.13.1 Oxford Nanopore Technologies Company Details
  • 10.13.2 Oxford Nanopore Technologies Business Overview
  • 10.13.3 Oxford Nanopore Technologies Next Generation Sequencing (NGS) Introduction
  • 10.13.4 Oxford Nanopore Technologies Revenue in Next Generation Sequencing (NGS) Business (2015-2020)
  • 10.13.5 Oxford Nanopore Technologies Recent Development
• 13.14 Bio-Rad Laboratories
  • 10.14.1 Bio-Rad Laboratories Company Details
  • 10.14.2 Bio-Rad Laboratories Business Overview
  • 10.14.3 Bio-Rad Laboratories Next Generation Sequencing (NGS) Introduction
  • 10.14.4 Bio-Rad Laboratories Revenue in Next Generation Sequencing (NGS) Business (2015-2020)
  • 10.14.5 Bio-Rad Laboratories Recent Development
• 13.15 DNASTAR
  • 10.15.1 DNASTAR Company Details
  • 10.15.2 DNASTAR Business Overview
  • 10.15.3 DNASTAR Next Generation Sequencing (NGS) Introduction
  • 10.15.4 DNASTAR Revenue in Next Generation Sequencing (NGS) Business (2015-2020)
  • 10.15.5 DNASTAR Recent Development
• 13.16 Biomatters
  • 10.16.1 Biomatters Company Details
  • 10.16.2 Biomatters Business Overview
  • 10.16.3 Biomatters Next Generation Sequencing (NGS) Introduction
  • 10.16.4 Biomatters Revenue in Next Generation Sequencing (NGS) Business (2015-2020)
  • 10.16.5 Biomatters Recent Development
• 13.17 Partek
  • 10.17.1 Partek Company Details
  • 10.17.2 Partek Business Overview
  • 10.17.3 Partek Next Generation Sequencing (NGS) Introduction
  • 10.17.4 Partek Revenue in Next Generation Sequencing (NGS) Business (2015-2020)
  • 10.17.5 Partek Recent Development
• 13.18 New England Biolabs
  • 10.18.1 New England Biolabs Company Details
  • 10.18.2 New England Biolabs Business Overview
  • 10.18.3 New England Biolabs Next Generation Sequencing (NGS) Introduction
  • 10.18.4 New England Biolabs Revenue in Next Generation Sequencing (NGS) Business (2015-2020)
  • 10.18.5 New England Biolabs Recent Development
• 13.19 Myriad Genetics
  • 10.19.1 Myriad Genetics Company Details
  • 10.19.2 Myriad Genetics Business Overview
  • 10.19.3 Myriad Genetics Next Generation Sequencing (NGS) Introduction
  • 10.19.4 Myriad Genetics Revenue in Next Generation Sequencing (NGS) Business (2015-2020)
  • 10.19.5 Myriad Genetics Recent Development
• 13.20 Macrogen
  • 10.20.1 Macrogen Company Details
  • 10.20.2 Macrogen Business Overview
  • 10.20.3 Macrogen Next Generation Sequencing (NGS) Introduction
  • 10.20.4 Macrogen Revenue in Next Generation Sequencing (NGS) Business (2015-2020)
  • 10.20.5 Macrogen Recent Development
• 13.21 GATC Biotech
  • 10.21.1 GATC Biotech Company Details
  • 10.21.2 GATC Biotech Business Overview
  • 10.21.3 GATC Biotech Next Generation Sequencing (NGS) Introduction
  • 10.21.4 GATC Biotech Revenue in Next Generation Sequencing (NGS) Business (2015-2020)
  • 10.21.5 GATC Biotech Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer